Pfizer Could Apply for Emergency Use of COVID-19 Vaccine by Late November
Share
[aggregation-styles]
The Wall Street Journal Subscription
Pfizer Inc. laid out a timetable for reaching key milestones in the development of its Covid-19 vaccine that could mean the shots start becoming available in the U.S. before year’s end.
Chief Executive Albert Bourla said Friday the company could start to see from a large study whether the vaccine works by the end of this month and would have data on its safety by the third week of November. If the preliminary results indicate the vaccine can work safely, Pfizer could ask U.S. health regulators to permit use by late November.
Read More →
The Wall Street Journal Subscription
Pfizer Inc. laid out a timetable for reaching key milestones in the development of its Covid-19 vaccine that could mean the shots start becoming available in the U.S. before year’s end.
Chief Executive Albert Bourla said Friday the company could start to see from a large study whether the vaccine works by the end of this month and would have data on its safety by the third week of November. If the preliminary results indicate the vaccine can work safely, Pfizer could ask U.S. health regulators to permit use by late November.
Read More →
RELATED TOPICS:
Categories
Latest
Videos
Local /
13 minutes ago
Visalia Shooting Leaves Two Dogs Dead, Two Injured
World /
33 minutes ago
Poland to Try Suspect in Alleged Russian Plot to Assassinate Zelenskiy
Politics /
37 minutes ago
Trump to Make Golden Dome Announcement on Tuesday, US Official Says
Business /
46 minutes ago
Musk Says He Is Still Committed to Being Tesla CEO in 5 Years’ Time
Courts /
17 hours ago
Supreme Court Allows Trump to Strip Legal Protections for Venezuelans Who Risk Deportation
SF 49ers /
17 hours ago
49ers Sign All-Pro Linebacker Fred Warner to $63M Extension
Crime /
17 hours ago
